efaroxan has been researched along with Decerebrate Posturing in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dreshaj, IA; Ernsberger, P; Erokwu, BO; Haxhiu, MA; McFadden, CB | 1 |
| Berridge, TL; Doxey, JC; Roach, AG; Smith, CF | 1 |
2 other study(ies) available for efaroxan and Decerebrate Posturing
| Article | Year |
|---|---|
Moxonidine acting centrally inhibits airway reflex responses.
Topics: Acetylcholine; Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Benzofurans; Blood Pressure; Decerebrate State; Dogs; Efferent Pathways; Electric Stimulation; Heart Rate; Imidazoles; Imidazoline Receptors; In Vitro Techniques; Lung; Muscle, Smooth; Nerve Fibers; Neurons, Afferent; Receptors, Drug; Reflex; Trachea; Vagus Nerve | 1999 |
Selectivity profile of the alpha 2-adrenoceptor antagonist efaroxan in relation to plasma glucose and insulin levels in the rat.
Topics: Adrenergic alpha-Antagonists; Animals; Benzofurans; Blood Glucose; Brimonidine Tartrate; Clonidine; Decerebrate State; Dioxanes; Dose-Response Relationship, Drug; Epinephrine; Idazoxan; Imidazoles; Insulin; Male; Muscles; Prazosin; Quinoxalines; Rats; Rats, Inbred Strains; Vas Deferens | 1992 |